Farallon Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Farallon Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-49,995	Closed	-$72.5K	–	195
2024 Q1	$72.5K	Hold	49,995	–	–	﹤0.01%	159
2023 Q4	$4.37K	Hold	49,995	–	–	﹤0.01%	155
2023 Q3	$7.5K	Hold	49,995	–	–	﹤0.01%	157
2023 Q2	$4.5K	Hold	49,995	–	–	﹤0.01%	166
2023 Q1	$2.75K	Hold	49,995	–	–	﹤0.01%	190
2022 Q4	$2.28K	Hold	49,995	–	–	﹤0.01%	232
2022 Q3	$4K	Hold	49,995	–	–	﹤0.01%	299
2022 Q2	$7K	Hold	49,995	–	–	﹤0.01%	307
2022 Q1	$16K	Hold	49,995	–	–	﹤0.01%	316
2021 Q4	$25K	Hold	49,995	–	–	﹤0.01%	296
2021 Q3	$29K	Hold	49,995	–	–	﹤0.01%	295
2021 Q2	$50K	Buy	+49,995	New	+$37.9K	﹤0.01%	289

Farallon Capital Management's AEON.WS Position: Q2 2024 in Review

Farallon Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 49,995 shares — an estimated $72.5K sold.

Farallon Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $72.5K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Farallon Capital Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Farallon Capital Management sold 49,995 AEON Biopharma Inc shares in Q2 2024, an estimated $72.5K.
Farallon Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
Farallon Capital Management's AEON Biopharma Inc position peaked at $72.5K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.